Stewart, K., Rajkumar, V., Dimopoulos, M., Masszi, T., Spicka, I., Oriol, A., Mihaylov, G., Goranova-Marinova, V. Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma. London: 2015 142-152,.
Stewart, K., Rajkumar, V., Dimopoulos, M., Masszi, T., Spicka, I., Oriol, A., Mihaylov, G., Goranova-Marinova, V. Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma. London: 2015 142-152,.
Stewart, K., Rajkumar, V., Dimopoulos, M., Masszi, T., Spicka, I., Oriol, A., Mihaylov, G., Goranova-Marinova, V. (2015) Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma, London: 142-152,.
Stewart, K., Rajkumar, V., Dimopoulos, M., Masszi, T., Spicka, I., Oriol, A., Mihaylov, G., & Goranova-Marinova, V. (2015). Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma. New England Journal of Medicine, The, 372 (2), 142-152.
Stewart K, Rajkumar V, Dimopoulos M, Masszi T, Spicka I, Oriol A, et al. Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma. New England Journal of Medicine, The. 2015; 372(2): 142-152.
